Endothelin-1 is a 21-amino acid peptide first characterized as a potent vasoactive compound synthesized by endothelial cells. Because of its high level cell-restricted pattern of expression, we have employed this gene as a model for investigating the DNA and protein elements that mediate endothelial cell-specific gene expression. In this study we have identified a complex positive regulatory region located at base pairs ؊364 to ؊320 in the murine endothelin-1 gene. This region consists of three functionally dependent elements, ETE-C, ETE-D, and ETE-E, which are all required for full activity. When a 43-base pair fragment containing these three elements was employed in heterologous promoter experiments, this sequence was capable of increasing transcriptional activity in an endothelial cell-specific fashion. None of the elements contains a recognized consensus sequence known to bind transcriptional regulatory proteins in higher eukaryotes; however, each element does appear to mediate protein binding. The combination of all three elements promotes binding of a protein complex that is endothelial cell-specific. This is the first evidence for an endothelial cell-specific DNA regulatory element and cognate binding proteins.
Endothelin-1 (ET-1)
1 is a potent vasoconstrictor and smooth muscle cell mitogen expressed in endothelial cells of the vascular wall. Because of the potential role of ET-1 in vascular diseases such as hypertension and atherosclerosis, the biology of this vasoactive factor and its high affinity receptors has been extensively studied (1, 2) . In particular, numerous studies have investigated the regulation of the ET-1 gene by hormones and physical factors such as hypoxia and shear stress (1) (2) (3) . ET-1 gene targeting experiments have demonstrated that ET-1 is essential for the normal development of pharyngeal arch-derived tissues and is also involved in the normal development of the heart and great vessels (4, 5) .
We have employed the ET-1 gene to investigate transcriptional regulation in endothelial cells. The high level cell-restricted expression of ET-1 has made it an attractive model for such studies. Reporter gene transfection experiments have indicated that the human ET-1 (hET-1) promoter has at least two essential protein binding motifs. One of these, TTATCT, at bp Ϫ136 to Ϫ131 in the human gene is similar to sequences associated with other eukaryotic genes that interact with one or more GATA factors (6 -8) . Members of the family of GATA binding proteins recognize a consensus sequence motif, WGA-TAR, through a conserved C4 zinc finger DNA binding domain. Data from this lab and others have implicated GATA-2 as the factor that regulates transcription of the hET-1 gene through this GATA site (6, 9) . A GATA motif has subsequently been identified in a number of other endothelial cell-specific genes (10 -12) . However, transcriptional activation by GATA cannot account for cell-restricted expression of hET-1, since GATA-2 appears to be expressed in many cell types in the adult (6, 9) . Also, endothelial cells appear to arise and contribute to blood vessel formation in mice lacking this transcription factor (13) . A second essential protein binding motif identified in the hET-1 promoter, TGACTAA, is capable of mediating the binding of Jun and Fos family members and confers AP1 responsiveness on a heterologous promoter (14) . In addition, this element appears essential for constitutive base-line activity of the hET-1 promoter in endothelial cells in culture. Proteins binding to these two sites in the hET-1 promoter appear to activate transcription in a synergistic fashion, perhaps through direct protein-protein interaction (15) .
Expression in transgenic mice of reporter constructs containing various regions of the hET-1 gene revealed low level endothelial cell expression, with expression in additional cell types apparently due to regulatory regions flanking the integration site (16) . 2 These data suggested that a distant enhancer element in the hET-1 gene is essential for high level cell-specific integration site-independent expression. In contrast to these findings with the human promoter, recent transgenic experiments with the murine ET-1 (mET-1) promoter have indicated that 6 kbp of upstream flanking sequence, in conjunction with the first untranslated exon and first intron, is able to direct high level endothelial cell-specific expression (17) . Taken together, these experiments suggest that the mET-1 endothelial cell enhancer element is more proximally located in the murine gene than in the human gene.
To identify the proximal regulatory elements that direct in vivo expression of the mET-1 gene, we have conducted in vitro reporter gene transfection experiments. These experiments revealed a positive transcriptional element located in the 5Ј-flanking region at Ϫ364 to Ϫ347 bp. This element, named ETE-C, could not function without an adjacent sequence containing at least two additional elements, ETE-D and ETE-E, between Ϫ347 and Ϫ320 bp. All three elements were shown to be necessary for function. When a 43-bp fragment containing these three elements was employed with a heterologous promoter, transcriptional activity was selectively increased in en-dothelial cells. Oligonucleotides encoding each of the elements was capable of binding proteins in a variety of cell types. Only ETE-C appeared to bind a protein specific to the endothelial cell lineage. Interestingly, oligonucleotides containing all three elements produced a complex that was endothelial cell-specific. This complex functional region of the mET-1 promoter represents the first sequence to be shown to regulate transcription in an endothelial cell-specific fashion.
EXPERIMENTAL PROCEDURES
Reporter Gene Construction-Lambda phage clones containing the mET-1 gene were cloned from a 129SV/J genomic library, employing a mET-1 cDNA cloned in this laboratory. Clones were restrictionmapped, and two restriction fragments were subcloned into Bluescript KSII for reporter gene construction. These two fragments were a 4.5-kbp HindIII/BamHI fragment containing Ϫ5900 bp to Ϫ1400 bp (p5900H/B) and a 3.5-kbp EcoRI/EcoRI fragment containing Ϫ2400 bp to ϩ1100 bp (p2400R/R). To generate the reporter plasmid p5900, the region between Ϫ5900 and ϩ1100 bp was reconstituted in a single plasmid using the internal BamHI site and the luciferase reporter gene on a BglII/BamHI fragment cloned into the BglII site in the 5Ј-untranslated region of the first exon. The reporter plasmid p1400 was constructed as follows. A plasmid p1400B/B was prepared by isolating a BamHI/BamHI fragment containing bp Ϫ1400 to ϩ1000 bp from p2400R/R and subcloning into Bluescript KS II at the BamHI site. The luciferase gene isolated from pGL2-Basic (Promega), again as a BglII/ BamHI fragment, was subcloned into the BglII site in the first exon of the mET-1 gene. The first intron of mET-1 was removed by digesting with SacI, and the plasmid was ligated to generate the p1400 reporter. The reporter construct p863 was prepared by digesting p1400B/B with PstI to remove the upstream sequence from Ϫ1400 to Ϫ864 bp and then replacing the NheI/NotI fragment in this plasmid with the NheI/NotI fragment from p1400. The reporter p286 and p149 were prepared by subcloning an NheI/BglII mET-1 fragment or an XbaI/BglII mET-1 fragment, respectively, into the NheI and BglII sites of pGL2-basic.
Additional reporter vectors were constructed as follows. A promoter reporter deletion series with 5Ј termini spanning Ϫ863 to Ϫ286 base pairs was produced from p863 by employing the KpnI and XhoI sites, resulting in p660, p466, p409, p384, p364, p355, and p347. The p863mut and p863del were constructed by using polymerase chain reaction reactions with two forward primers (pGL-2 and P-1) and three reverse primers (pGL-1, P-2, and P-3) and p863 as a template. The pGL-1 and pGL-2 primers (Promega) were sequencing primers for the pGL2-basic vector. The sequences of the three other primers were P-1 (5Ј-AATTAAATAGATTGTATT, Ϫ382 to Ϫ365 bp), P-2 (5Ј-GTGGCTC-ATACTTTTCAT, Ϫ365 to Ϫ348 bp), P-3 (5Ј-TCCAATGGGGTGACTTT, Ϫ348 to Ϫ331 bp). The underlined letters indicate the mutated bases. The polymerase chain reaction products of reactions with primer pairs pGL-1/P-1, pGL-2/P-2, and pGL-2/P-3 were cloned into pCR II vector (Invitrogen Corp). Fragments were then excised and combined as follows. The pGL-1/P-1 fragment was excised with XbaI and EcoRI and ligated along with the pGL-2/P-2 fragment or with pGL2/P-3 fragment excised with EcoRI and BglII into pGL2-basic at the NheI and BglII sites. The resulting plasmids were named p863mut and p863del, respectively.
A series of reporter constructs were prepared for the reconstitution experiments. The plasmids p286ϩETE-C, p286ϩETE-C/D, p286ϩETE-C/D/E were generated by cloning annealed complementary oligonucleotides encoding one copy of the ETE-C, ETE-C/D, or ETE-C/D/E elements into KpnI and SacI sites of p286. The complementary oligonucleotides ETE-C/mD/E and ETE-C/D/mE encoding the mutant D and E elements were cloned into p286 at KpnI and SacI sites, respectively, to generate the plasmids p286ϩETE-C/mD/E and p286ϩETE-C/D/mE.
For heterologous promoter experiments, the reporter plasmids pSV40ϩ(1X)ETE-C/D/E and pSV40ϩ(3X)ETE-C/D/E were prepared by cloning one copy or three copies of ETE-C/D/E oligonucleotides into KpnI and SacI sites of pGL2 promoter construct (Promega) containing the minimal SV-40 promoter. The p149ϩ(1X)ETE-C/D/E and p149ϩ(3X)ETE-C/D/E were constructed by cloning one or three copies of the ETE-C/D/E oligos into the same restriction sites in the p149 minimal mET-1 promoter. All plasmids were verified by sequencing.
Cell Culture and Transfection-Bovine aortic endothelial cells (BAEC) were grown on gelatin-coated 6-well plates in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (Hyclone), 600 g of glutamine/ml, 100 units of penicillin/ml, and 100 g of streptomycin/ml. BAEC at passages 4 -7 were used for transfection. The NIH 3T3 mouse fibroblast cell line and the C6 glial tumor cell line were also grown on 6-well plates in the same medium. Cultured cells were transfected with 1 g of reporter construct DNA that had been incubated with lipofectAMINE (Life Technologies, Inc.). As a means for correcting for transfection efficiency, 1 g of the constitutive pSV␤gal construct was also included in each transfection. Transfection was carried out by incubating cells in the presence of DNA for 5 h. Subsequently, cells were cultured in fresh media containing 10% fetal calf serum. Cell extracts were prepared 2 days after transfection, and the luciferase and ␤-galactosidase assays were performed as described previously (15) .
The relative luciferase activity was calculated as the ratio of light units to ␤-galactosidase units. These corrected light units have been divided by the value obtained with the promoterless pGL2-basic plasmid, which was included in all transfections. The transfections were done in duplicate and performed at least three times for each reporter construct.
Electrophoretic Mobility Shift Assays-Complementary oligonucleotides encoding the ETE-C, ETE-C/D, and ETE-C/D/E elements were labeled with T4 polynucleotide kinase and employed in binding reactions with nuclear extracts from BAEC and other cell types as described previously (15) . The specificity of binding was ascertained by competition with a 100-fold molar excess of cold oligonucleotides added to the reaction mixture.
RESULTS

Identification of an Upstream Positive Regulatory Region-
Transgenic experiments had shown that a 7-kbp region of the mET-1 gene, including 5.9 kbp of 5Ј-flanking sequence and the first exon and intron, was sufficient to confer high level expression in endothelial cells in vivo (17) . Reporter gene transfection studies thus began with this same region of the mET-1 gene, with the luciferase gene cloned into a BglII site of the first untranslated exon (Fig. 1, A and B) . Transfections of this construct, p5900, were performed with BAEC and NIH-3T3 cells. A constitutive ␤-galactosidase vector was co-transfected and employed for correction of transfection efficiency. Transcription of p5900 was endothelial cell-specific, with a high level of transcriptional activity (Fig. 1C) . In the BAEC used in these experiments, there was no difference in reporter gene activity with removal of the first intron, most of the first exon, and the majority of the 5Ј-flanking sequence (p1400 and p863, Fig. 1C ). However, there was a 3-4-fold decrease in reporter gene activity when the 5Ј-flanking sequence was decreased from Ϫ863 to Ϫ286 bp, (p863 versus p286, Fig. 1 ). There was no difference in the activity of these reporter genes in NIH-3T3 cells, suggesting that the transcriptional action of this region may be cellspecific. Activity did not change substantially in either cell type when the flanking sequence was further decreased to 149 bp (p286 versus p149, Fig. 1C ). The p149 construct contained the GATA and AP1 sites, and when these were deleted in shorter constructs, there was an approximately 8-fold decrease in activity (data not shown). These data suggest that a positive regulatory element, perhaps endothelial cell-specific in action, is located between Ϫ863 and Ϫ286 bp of the mET-1 promoter. This element was given the name ETE-C.
To further investigate the regulatory activity of this region, a fragment containing Ϫ863 to Ϫ286 bp of mET-1 was cloned in the native orientation upstream of the minimal Ϫ149 bp construct of the mET-1 gene, the minimal Ϫ204-bp promoter of the human ET-1 (hET-1) gene, and a minimal promoter derived from SV40 ( Fig. 2A ). Transfections were performed in BAEC. Constructs with both the mET-1 and hET-1 promoters showed 3-4 times greater reporter activity when the Ϫ863 to Ϫ286 fragment was included. The pSV40 vector containing the mET-1 fragment showed an approximate 2-fold increase in activity in BAEC (Fig. 2B) . These results further suggest that this region of the mET-1 gene contains a positive regulatory element.
Localization of the Regulatory Element-To further define this cis-acting sequence of the mouse ET-1 gene, functional analysis was performed with constructs containing promoter fragments derived from an exonuclease-nested deletion series (Fig. 3A) . Transfection of reporter constructs containing 364 to 863 bp of upstream sequence produced similar high levels of reporter gene activity in BAEC. The apparent lower activity of constructs containing greater than 384 bp of sequence was consistent but was not investigated with further studies. When the 5Ј-flanking sequence was decreased from 364 to 355 bp, there was a significant drop in transcription rate. A second drop in activity was seen when 8 bp were removed from p355 to produce a 347-bp upstream fragment. Overall, the decrease in reporter activity between p364 and p347 was approximately 3.5-fold. These data suggest that ETE-C is a single positive regulatory element that is partially inactivated in the p355 construct and fully inactivated in the p347 construct or two separate binding sites with one site encoded between Ϫ364 and Ϫ355 bp and a second between Ϫ355 and Ϫ347 bp. In either case, the positive functional activity identified as ETE-C appears to be restricted to the 18-bp sequence between Ϫ364 and Ϫ347 bp.
Employing the sequence of element ETE-C in data bank searches of known DNA regulatory elements revealed no evidence of previously characterized protein binding sites. Whereas there are no palindromes in this sequence, there are two repeating motifs, TACTT and TTCAT. There is one copy of each of these repeats between Ϫ364 bp and Ϫ355 bp and a second between Ϫ355 bp and Ϫ347 bp, so either of these could represent a duplicated protein binding site that is the functional ETE-C. Comparison between the sequences of the mouse and rat genes reveals that this region is virtually identical in these two species (Fig. 4A) . However, the human sequence is divergent, with the 5Ј TACTT repeat being replaced with TG-GCT. To investigate this difference and to further define the ETE-C sequence, site-directed mutagenesis was employed to convert the ETE-C sequence in the mouse p863 reporter to the human sequence (Fig. 4, A and B) . Changing the three base pairs of the 5Ј TACTT repeat resulted in loss of approximately half of the activity of the reporter construct, similar to that seen with deletion of the sequence Ϫ364 to Ϫ355 with the mET-1 constructs (Fig. 4C ). When 13 of the 18 base pairs of the ETE-C were replaced with a linker, the activity level of the mutated 863-bp promoter decreased to that of the 286-bp promoter (Fig. 4C) . These data suggest that TACTT is the functional sequence in the ETE-C element and that the human and mouse differ in their use of this transcriptional element.
ETE-C Requires Two Additional Proximal Elements for Function-To determine whether the ETE-C element could function in the absence of the flanking sequence, reconstitution experiments were conducted with complementary oligonucleotides encoding this element (Fig. 5, A and B) . The native p286 and p863 reporter constructs were included in these experiments as negative and positive controls, respectively. When one copy of the oligonucleotides encoding ETE-C was cloned upstream of the p286 promoter construct, the 18-bp element failed to activate the promoter in transient transfection experiments in BAEC. Similarly, there was no increase in transcription when the copy number of the oligonucleotides was increased to three or six (data not shown). We then investigated the potential requirement for downstream flanking sequence. In initial experiments, the sequence CCAATG (Ϫ345 to Ϫ340 bp), which is immediately downstream of ETE-C, was included in the oligonucleotides. This region was designated ETE-D. The combination of ETE-C plus ETE-D also failed to increase reporter activity. Next, an additional sequence extending to Ϫ320 bp was included in the oligonucleotides, and this new region was designated ETE-E. A single copy of these 43-bp oligos encoding Ϫ364 to Ϫ320 bp increased reporter gene activity more than 3-fold. To verify the specificity of this result and further define the active sequences in ETE-D and ETE-E, oligonucleotides containing point mutations were made and evaluated for activity. Activity was lost when the sequence CCAATG of ETE-D was replaced with CGGTAG, implicating these base pairs in the functional element and indicating that both ETE-D and ETE-E are essential for activity of this complex regulatory region. Activity was also lost when the sequence GT-GACT of ETE-E was replaced with GCATGT, implicating these base pairs in the functional activity of this element and again demonstrating that all three elements are necessary for function.
ETE-C/D/E Is an Endothelial
Cell-specific Regulatory Element-In a final series of reporter transfection studies, the activity of combined elements ETE-C/D/E was evaluated in nonendothelial cells and in the context of a heterologous promoter (Fig. 6, A and B) . First, the activity of one and three copies of the 43-bp ETE-C/D/E oligonucleotides cloned upstream of the minimal p149 mET-1 promoter was evaluated in fibroblasts and various tumor cell lines as well as BAEC (Fig.  6, A and B) . For most of the nonendothelial cell lines, a minimal increase was seen with the addition of one or three copies of the ETE elements. For example, NIH 3T3 cells showed less than a 2-fold increase with one ETE and an approximate 3-fold increase with three copies. By contrast, BAEC had more than a 5-fold increase with the addition of a single ETE and a 15-fold increase with the addition of three copies of the ETE. The C6 glial tumor cell line was the most responsive nonendothelial cell. Although the overall level of activity of the minimal ET-1 promoter in these cells was low, the relative increase seen with inclusion of one ETE was approximately 3, and the increase with three copies of the ETE was similar in magnitude to that seen with the BAEC. Similar experiments were conducted by cloning oligonucleotides encoding one or three copies of the ETE-C/D/E element into a minimal SV40 promoter construct (Fig. 6, A and C) . Evaluation of reporter activity was conducted with transfections into the same cell lines as described previously. With these experiments, a large consistent increase was seen only in BAEC. There was a 3-fold increase in BAEC with a single ETE element and more than an 18-fold increase with three elements. Like the NIH 3T3 cells, most cells showed no increase even with the three-element construct. The glial tumor cell line showed no increase with a single element and only a 3-fold increase with three copies. Taken together, these data in nonendothelial cells with a heterologous promoter construct provide strong support for the independent and endothelial cellspecific nature of this transcriptional regulatory element.
ETE-C, ETE-D, and ETE-E Each Bind Protein, and the Combination of These Elements Mediates Binding of an Endothelial
Cell-specific Complex-To identify nuclear proteins that bind the ETE elements, gel mobility shift assays were performed with oligonucleotides and nuclear extracts from BAEC and various nonendothelial cell lines. In the first series of experiments, oligonucleotides encoding the ETE-C sequence were employed. A number of complexes were seen. Most significant among these, a rapidly migrating band was observed with the BAEC extract that was not seen with extracts from the other cell types (Fig. 7A, arrow) . Interestingly, this band was not seen with extract from the murine embryonic endotheliallike yolk sac cells. Although these cells share a number of characteristics of mature endothelial cells, they do not express mET-1. The complex observed with BAEC nuclear extract appeared specific to endothelial cells and to correlate with expression of mET-1. Additional bands observed with BAEC extract were also seen with extracts from yolk sac cells and HeLa cells (Fig. 7A, arrowheads) .
Similar experiments were conducted with oligonucleotides
The regulatory region increases transcription of the minimal mouse and human ET-1 promoters. A, minimal promoter reporter gene constructs with the mouse (mET-1) regulatory region. The mET-1 regulatory region includes base pairs Ϫ863 to Ϫ286, the mET-1 promoter includes base pairs Ϫ149 to ϩ132, the human ET-1 (hET-1) promoter includes base pairs Ϫ204 to ϩ174, and the minimal SV40 promoter construct was derived from the pGL2-promoter vector. B, comparison of luciferase expression of the constructs with and without the mET-1 regulatory region.
encoding the ETE-D region (Fig. 7B) . Although a shifted complex was identified with the BAEC nuclear extract, it did not appear to represent an endothelial cell-restricted DNA-binding protein. Similar migrating complexes were seen with extracts from other cell lines. Competition experiments with oligonucleotides encoding the consensus binding sequence for the c/EBP class of transcription factors suggested that the protein complexes identified in these experiments are not members of this family (Fig. 7B) .
GMSA experiments with oligonucleotides encoding ETE-E suggest that this region binds ubiquitously expressed binding proteins. A single protein-DNA complex was seen with extract from all cell lines studied (Fig. 7C) . Although the sequence encoded in this region has homology to the well characterized AP1 binding sequence, oligonucleotides encoding the bona fide AP1 sequence were not able to compete for binding of this complex to the ETE-D element.
GMSA experiments employing oligonucleotides encoding ETE-C alone (ETE-C), ETE-C plus ETE-D (ETE-C/D), or ETE-C plus ETE-D and ETE-E (ETE-C/D/E)
suggest that all three binding sites can be occupied simultaneously (Fig. 7D) . BAEC nuclear extract was incubated with the various oligonucleotide pairs, and the electrophoresis pattern was compared on a single gel. The endothelial cell-specific complex seen with the ETE-C probe in Fig. 7A is not resolved from a large rapidly migrating complex, resulting in two DNA-protein complexes seen with the ETE-C probe in this experiment (Fig. 7D, solid and dotted arrows). When the sequence for ETE-D was included in the oligonucleotides, both bands appeared to migrate more slowly (Fig. 7D) . The combination of all three binding sites resulted in even further retardation of the complexes. It seems most likely that this increase in retardation with the inclusion of additional binding sites represents the binding of additional proteins to the oligonucleotide probes. In this case, the change in migration rate would reflect an increase in molecular mass of the protein-DNA complex. Although the migration of protein-DNA complexes in these native gels is felt to be determined primarily by the DNA binding protein, with less contribution by the size or sequence of the DNA probes, it is of course possible that the observed differences in migration reflect differences in the DNA probes.
In a final series of GMSA experiments, we have investigated the cell-specific pattern of protein binding to the ETE-C/D/E oligonucleotides. Forty-three-bp oligos encoding all three elements were employed in GMSA with extract from BAEC, NIH 3T3 cells, HeLa cells, rat aortic smooth muscle cells, and JEG3 choriocarcinoma cells. Interestingly, the retarded complexes seen with the different cellular extracts were quite different. The BAEC extract produced a complex pattern with three prominent bands. The two more rapidly migrating complexes appeared to co-migrate with complexes formed with extract from other cell lines (Fig. 7E, arrowheads) . However, the slowest migrating complex seen with the BAEC extract was unique to this cell type (Fig. 7E, arrow) . Protein binding to the combi -FIG. 3 . Localization of the ETE-C regulatory element. A, schematic of reporter constructs derived from an exonuclease deletion series. Numbering of the 5Ј terminus is relative to the transcription start site, and all constructs terminate at the BglII site at ϩ132 in the untranslated portion of the first exon. B, relative luciferase activity of the constructs was determined as described in Fig. 1 , except transfections were performed only in BAEC.
Endothelial Cell-specific Regulatornation of all three elements thus produced an endothelial cellspecific binding complex.
DISCUSSION
The endothelial cell controls a number of important physiological processes in the blood vessel wall. Some of the functions served by this cell include leukocyte adhesion and movement through the blood vessel wall, local regulation of blood vessel tone, modulation of the immune response, and the local balance between thrombosis and thrombolysis (18, 20 -25) . The endothelial cell has thus been postulated to play a central role in disease processes that are primarily vascular, such as hypertension and atherosclerosis, and also participate in a wide variety of immune and inflammatory diseases that are not primarily vascular in nature. Also, the endothelial cell regulates all forms of vascular development in both the embryo and the adult animal (26) . Given the recent interest in pharmacological manipulation of blood vessel growth as a therapy for diverse disease processes, there has been increased interest in the mechanisms by which endothelial cells regulate vascular formation (27) . Thus, insight into the basic biology of this important cell type should aid in the understanding and treatment of a number of disease processes.
To explore issues of basic endothelial cell biology, a number of laboratories have investigated transcriptional regulation in this cell type. To investigate the DNA and protein elements that are responsible for transcription in endothelial cells, a number of promoters associated with genes expressed primarily in endothelial cells have been studied. Among these are the genes for plasminogen activator inhibitor-1, granulocyte macrophage colony stimulating factor, endothelin-1, thrombomodulin, von Willebrand factor, platelet-derived growth factors A and B, intracellular cell adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin, P-selectin, tissue factor, angiotensin converting enzyme, inducible and constitutive NO synthase, superoxide dismutase, flk-1, and flt-1 (8, 10, 11, 28 -42) . This work has provided significant insights into the mechanism of hormonal, cytokine, and even physical force regulation of gene transcription in this cell type but has not yielded significant progress toward understanding the DNA and protein elements that are specific to the endothelial cell. A difficulty with these in vitro studies in endothelial cells is that they have been conducted with gene segments that are known to not be capable of directing cell-restricted expression of reporter genes in vivo in transgenic animals or have not been evaluated in this context. The lack of correlation with in vivo information has retarded progress in the field. Thus, for the studies reported here, we have employed a region of the mouse ET-1 gene that has been shown to direct high level endothelial cell-restricted expression in vivo (17) . Interestingly, experiments in this laboratory employing comparable regions of the human ET-1 gene in reporter constructs in transgenic mice were unsuccessful, suggesting a fundamental difference in the location or use of DNA transcription elements (16) . 3 In these studies we have identified a complex regulatory 3 X. Bu and T. Quertermous, unpublished data.
FIG. 4.
Mutation of mET-1 gene sequence between ؊363 and ؊347 abolishes the positive regulatory activity in this region. A, comparison of mouse, human, and rat (rET-1) gene sequences in the region of the mET-1 positive regulatory element ETE-C. ETE-C sequence is underlined. B, mutations that were introduced into the p863 construct by either site-directed mutagenesis (mutation of p863) or by linker substitution (deletion of p863) are shown; altered base pairs are underlined. C, relative luciferase activity of the wild type and mutated p863 constructs was determined as outlined in Fig.  1 and compared with the negative control construct p286.
region in the mET-1 gene that appears to confer endothelial cell-specific transcriptional activity and to bind proteins or protein complexes that are restricted to the endothelial cell. Between Ϫ364 and Ϫ320 bp of the mET-1 gene there are at least three functional elements, all of which are required for full activity. We have not been able to footprint this region but have been able to identify the functional elements through GMSA and reconstitution experiments employing oligonucleotides encoding mutant sequences. There is some homology of the elements that we have defined as ETE-D and ETE-E to known consensus binding sites, but our data strongly suggests that all three sites are unique. The implication of this observation is that these elements mediate binding of novel transcription factors.
Although we have not yet defined the specific binding sequence, it is likely that the core functional base pairs in element ETE-C are TACTT. Mutation of this sequence results in a complete loss of activity. This sequence has not been previously described in the context of transcriptional activation or protein binding activity. Interestingly, the human ET-1 promoter has only one of these elements, whereas the murine and rat promoters have two copies. When the murine promoter was mutated to the human sequence, there was a decrease in transcriptional activity. It is likely that the additional copy of the ETE-C element contributes to the higher base-line activities of the mET-1 promoter compared with the hET-1 promoter in cultured cells. It is unclear whether this difference in the human and mouse promoters might account for differences in the ability of these promoters to function in an integration-independent fashion in vivo in transgenic mice. This possibility will have to be formally addressed experimentally.
Element ETE-D contains the essential nucleotide sequence CAAT. Although this is the same core sequence found in the DNA binding sites that mediate interaction of members of the c/EBP transcription factor family, the sequence flanking this region does not match the known consensus binding sites (43) . Also, when oligonucleotides encoding bona fide c/EBP binding sites were employed as competitors in GMSA experiments, they were unable to compete for binding to the ETE-D element. Although there are clear differences in the binding patterns observed in GMSA between different cell types when oligonucleotides encoding ETE-D were employed as probes in the binding reaction, each complex seen with endothelial cell extract was also seen in several other cell types.
Element ETE-E, which includes the functional sequence TGACTTT, has homology to the well characterized AP1 binding sequence TGACTCA that has been shown to bind bZIP factors that constitute the Jun and Fos family of transcriptional regulators (19, 44 -46) . However, sequences identical to ETE-E have been studied in vitro and shown not to bind Jun and Fos family members (47) . Also, when oligonucleotides encoding bona fide AP1 sites were employed as competitors in GMSA experiments, they did not compete for the proteins interacting with ETE-E. In addition, when antisera specific for Fos and Jun were employed in binding reactions with the ETE-E probe, they did not block or supershift the shifted complex (data not shown). Positive control experiments indicated that the antisera and extract were functional in these experiments. It thus seems very unlikely that ETE-E represents an AP1 site. The similar binding pattern that is observed in GMSA experiments employing extracts isolated from a number of different cultured cell lines suggests that this element mediates interaction with ubiquitous transcription factors.
This complex region of the mET-1 promoter provides the first evidence for endothelial cell-specific DNA binding proteins and initial insight into mechanisms of endothelial cell-specific activation of transcription. Protein binding by the oligonucleotides encoding ETE-C produces a complex binding pattern that differs between nuclear extracts derived from different cell culture lines. Most significant is the presence of an endothelial FIG. 5 . The mET-1 regulatory element ETE-C is one of three adjacent interdependent regulatory elements that are all required for the transcriptional activity of this region of the promoter. The additional downstream elements have been named ETE-D and ETE-E. A, DNA sequence of mET-1 gene between base pairs Ϫ364 and Ϫ320, with functional regions ETE-C, ETE-D, and ETE-E indicated. Underlined bases indicate regions that were shown by mutagenesis to be necessary for full transcriptional activity and thus, localize elements ETE-D and ETE-E. Also shown are oligonucleotides encoding wild type or mutated sequences that were cloned in native orientation upstream of the mET-1 promoter in the construct p286. Lowercase letters indicate base pairs in the oligonucleotides employed for cloning. B, activities of the p286 and p863 constructs are shown as negative and positive control, along with reporter constructs containing the various oligonucleotides shown in A. Transfections were performed in BAEC as outlined in Fig. 1. cell-specific complex observed with nuclear extract from BAEC. Also, an endothelial cell-specific complex is observed in GMSA with oligonucleotides encoding the region between Ϫ364 and Ϫ320 bp and thus containing elements ETE-C, ETE-D, and ETE-E. The unique band observed with BAEC extract may represent the contribution of the endothelial cell-specific proteins that interact with ETE-C but might also represent the recruitment of additional cell-specific nuclear factors by the protein complex assembled on this region of the promoter. Further study of the endothelial cell-specific DNA binding complexes identified in association with these mET-1 promoter sequences should allow characterization of the protein factors involved. Such information would allow studies investigating the molecular basis of differentiation and lineage determination in this important cell type.
Results presented here differ from the preliminary studies previously published from another laboratory (17) . In those studies, experiments in cultured bovine pulmonary artery endothelial cells and human umbilical vein endothelial cells employing luciferase reporter genes identified a positive regulatory element between Ϫ5900 and Ϫ1400 bp of the mET-1 promoter. Our experiments could not detect such activity. The reporter constructs were identical, but the origin of the endothelial cells was different and might account for the observed differences. The previous studies did not investigate in detail a promoter sequence more proximal than Ϫ450 bp, so the ETE region described here was not identified.
These data provide important directions for further study. It will be of great interest to investigate through transgenic experiments the role of this region of the mET-1 gene in the regulation of endothelial cell-specific transcription in vivo. First, the importance of this region as a whole should be studied through evaluation of the ability of a promoter lacking this region to confer cell-specific integration site-independent expression on a transgene. If the region is found to be essential for in vivo cell-specific expression, individual elements might be evaluated in a similar fashion. Given the unique cell-specific binding pattern of ETE-C, this element would appear the most likely to confer cell specificity. FIG. 7 . Electrophoretic GMSAs indicate that ETE-C and the combination (Comp.) ETE-C/D/E bind endothelial cell-specific protein complexes. A, radiolabeled complementary oligonucleotide probes encoding the ETE-C element were employed in binding experiments with nuclear extract from BAEC, embryonic yolk sac cells (YS), epithelial HeLa cells, rat aortic smooth muscle cells (SMC), and NIH 3T3 embryonic fibroblasts. One retarded complex produced with the BAEC extract is unique (arrow), whereas the other retarded complexes are also seen in other cell extracts (arrowheads). Specificity of binding was verified by competition with 100-fold molar excess of unlabeled probe. B, oligonucleotide probes encoding the ETE-D element were employed in GMSA with extracts from NIH 3T3, HeLa, SMC, and JEG3 choriocarcinoma cells. A retarded complex representing specific binding was seen with BAEC extract (arrow). However, this complex was also seen with other cell extracts. In a similar separate GMSA experiment, complementary oligonucleotide probes encoding a c/EBP consensus binding site were used as cold competitors in the binding reaction with the ETE-D probe. These oligonucleotides at 100 molar excess failed to compete for binding to the ETE-D probe. C, oligonucleotides encoding the ETE-E element were employed in a GMSA experiment with extract from BAEC, NIH 3T3, smooth muscle, HeLa, and JEG3 cells. A single retarded complex is seen with all of the extracts. In a similar separate experiment, cold oligonucleotides encoding the AP1 consensus sequence were employed in the binding reaction. These probes at 100 molar excess failed to compete for binding to the ETE-E probe. D, oligonucleotide probes encoding ETE-C alone, ETE-C plus ETE-D, or ETE-C plus ETE-D and ETE-E were employed in GMSA with BAEC nuclear extract. The slower migrating complex seen with the ETE-C probe shifts upward (solid arrows3) as well as the more rapidly migrating complex (dashed arrows) with the inclusion of ETE-D and ETE-E binding sites. E, oligonucleotide probes encoding the ETE-C/D/E composite element were employed in GMSA experiments with extract from BAEC, NIH 3T3, HeLa, smooth muscle, and JEG3 cells. BAEC extract produced three specific retarded complexes. The slowest migrating complex (arrow) is not observed in extract from the other cell types, whereas the more rapidly migrating complexes (arrowheads) seen with BAEC extract are seen in at least one other extract.
